Company reportsPresentationsAnnouncementsCurrently selectedAnnual General MeetingFinancial calendarCorporate governanceData of sharesConferences, roadshowsAnalystsContact Announcements Extraordinary announcement08/01/17Composition of share capital and voting rights08/01/17Richter Group Report - 6 months to June 2017 07/28/17European Commission approved Reagila® (cariprazine) for the treatment of schizophrenia07/19/17Composition of share capital and voting rights 07/03/17 Archive
